EXOZ
eXoZymes, Inc.
NASDAQ: EXOZ · HEALTHCARE · BIOTECHNOLOGY
$9.98
-3.57% today
Updated 2026-04-30
Market cap
$87.31M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$7 – $18
Volume
0.0M
eXoZymes, Inc. (EXOZ) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-132.60%
ROA
-63.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $0.00 | $-1.21M | — | — | — |
| 2022 | $0.00 | $-1.40M | — | — | — |
| 2023 | $0.00 | $-2.04M | — | — | — |
| 2024 | $0.00 | $-5.86M | — | — | — |
| 2025 | $0.00 | $-9.16M | — | — | — |